Percutaneous catheter closure of patent ductus arteriosus (PDA) is difficult when the ductus is large and long or shows calcification. We created a patient-specific 3-dimensional (3D) model for PDA, with which we simulated device deployment, thereby selecting the device/size in a patient-by-patient manner. We assessed whether this 3D model is effective for catheter PDA closure.
P atent ductus arteriosus (PDA) usually causes leftright shunt or becomes a risk of endocarditis. PDA closure is necessary in cases of recurrent endocarditis or when the left-right shunt becomes clinically significant to the extent that left heart failure manifests or pulmonary hypertension occurs. There are two approaches for mechanical ductal closure: surgery or percutaneous catheter closure. Although not without rare complications, 1) percutaneous catheter closure is now widely used, 2) considering its lower-level invasiveness and effectiveness comparable to that of surgery. Percutaneous catheter PDA closure requires experienced cardiologists. In adult PDA cases, the PDA shape is sometimes complicated and arterial wall calcifications may be present, which often make this technique/deviceselection difficult. 3) In pediatric PDA cases, the ductus is sometimes very elastic/expandable, and thus, a device selected solely based on pre-procedural image analysis may not fit. 4) Even in patients without anticipated "technical difficulties", some accompanying conditions (i.e., severe heart conditions) may require "very smooth" device deployment. Improvements are necessary for catheter PDA closure.
A 3-dimensional (3D) printer based on various digital image data can be used to make a 3D model, and this technique is now clinically used to produce simulation models in various medical fields, including cardiology. 5) We preliminarily reported a new, less expensive, patientspecific hollow 3D model, which enabled the direct visualization/touching of the PDA lesion. 6) This led us to consider that this model may be practically useful for determining the PDA-device-closure procedure.
The present study aimed to clarify the following: 1) whether simulation using this model actually facilitates the selection of procedures/devices, 2) whether this model reduces the procedural/fluoroscopic time, or the amount of contrast medium, and 3) whether it improves doctors' understanding. † CoA indicates coarctation of the aorta. *This condition required CT because pre-procedure evaluation became difficult solely with ultrasound, and, thus, it was considered a "technically difficult" case. † These two factors also necessitated CT because the procedure was considered difficult. CT +/-indicates the anticipation of a difficult/less-difficult procedure, respectively. Krichenko type B, C, or D type indicates "window-type", "tubulartype", or "complex-type", respectively.
SIMULATION OF PATENT DUCTUS ARTERIOSUS OCCLUSION
Occluder (ADO: St. Jude Medical, St. Paul, MN, USA) was approved in Japan for catheter-PDA-closure in 2009. The 3D simulation model was introduced in this institute in October 2016. The study population (n = 7) consisted of consecutive PDA patients for whom catheter-PDAclosure with a 3D simulation model had been performed from October 2016 to June 2017, with its inclusion criteria described later. The criteria for employing catheter occlusion were consistent with the Structural Heart Disease Guidelines in Japan. 7, 8) The devices used were a Flipper coil, ADO, or AMPLATZER Vascular Plug II (AVP: St. Jude Medical, St. Paul, MN, USA) according to the criteria set by the above-mentioned guidelines and depending on the situation of each individual patient.
From February 2012 to June 2017, we performed catheter-PDA-closure in 42 patients (adult: 8, pediatric: 34). In this institute, we performed computed tomography (CT) before this procedure for patients in whom the procedure/device-selection were considered "difficult". Table  I indicates the criteria for employing pre-procedural CT, and, thus, "difficult" cases: roughly speaking, all adult cases, those with a larger diameter or longer PDA, those with unusual-type PDA morphologies, or those with some coexisting cardiac/thoracic conditions were considered difficult cases. We, specialist team members, discussed whether CT should be performed in a patient-by-patient manner based on these criteria. Figure 1 shows a diagram of patient selection. Of the 42 patients, 26 (all pediatric) did not require preprocedural CT and procedures were planned using only ultrasound; these were considered "non-difficult" cases, and excluded from the present analysis. Of the remaining MATSUBARA, ET AL Figure 2 . Photographs of the 3-dimensional printer and solid and hollow models. A: Nozzle (N), moving in the X direction, injects acrylonitrile-butadiene-styrene (ABS) resin and the platform (P) moves in the Y direction: this creates one layer of the 3D model. Then, due to the platform moving down in the Z direction, another layer is created on top of the previous one: this is repeated, finally creating a solid 3D model. B: A solid model. C: A hollow model. PA indicates pulmonary artery; PDA, patent ductus arteriosus; and DAO, descending aorta.
16, 5 patients were excluded from the study: Four patients (all before September 30th, 2016) received "coil embolization"; One patient underwent CT but the device was deployed 3 years after CT, with further CT just before the procedure considered to be no longer required. There remained 11 patients, who were divided into 2 groups: patients with 3D model (+) versus (−). As previously described, after October 2016, we employed 3D-model simulation for "difficult" cases: the former (3D (+): 5 adults and 2 pediatric patients) and the latter (3D (−): 3 adult patients and 1 pediatric patient) were patients who underwent device-deployment after versus before the introduction of the 3D-simulation model. In short, all "difficult" cases after October 2016 underwent deployment with the 3D model (study group: n = 7), whereas all those before this time (before September 30th, 2016) underwent it without the 3D model (control group: n = 4). This enabled a simple comparison between before versus after the introduction of the 3D model for "difficult" cases.
Creation of the 3D model: The 3D model was created using the method described by Mashiko, et al., 9) which was originally for cerebral aneurysm clipping. The 3D-model construction consisted of two steps: creation of a solid model, and then a hollow model, which were preliminarily described previously. 6) First, a solid model was created (Figure 2A , B). Data were from the image obtained by 64 scanning-plane multi-detector CT (MDCT: SOMATOM Definition FLASH (Siemens, Munich, Germany)) performed after the injection of 1.8 mL/kg of contrast medium (350 or 370 mg iohexol/mL). The number of voxels was 512 512 512. Digital Imaging and Communication in Medicine (DICOM) data were loaded into the Ziostation2 (Amin, Tokyo, Japan; 3D workstation) and OsiriX (Pixmeo, Geneva, Switzerland; 3D visualization and measurement software), and visualized on a personal computer. An area of interest was extracted from this image. Calcification around PDA, if present, and its resultant ductal narrowing were also reproduced. The results were converted to the Standard Triangulated Language (STL) file and a 3D solid model was fabricated with an UP Plus2 3D printer (Tiertime Technology, Beijing, China), which is small and light (245 260 350 mm, 5 kg). This 3D printer can create a solid model with a maximum size of 140 140 130 mm. From a nozzle, acrylonitrile-butadiene-styrene (ABS) resin melted at 260 was injected repeatedly to draw 0.15-mm-thick pattern layers on a platform, creating a hard, solid model. Second, a hollow elastic model was fabricated based on this solid model ( Figure 2C ). Commercially available molding translucent silicone (Zoukei-Mura, Kyoto, Japan) was mixed with an attached hardening agent (ZoukeiMura, Kyoto, Japan: 10% volume), which was used to evenly coat (1-mm thick) the surface of the ABS-solid model: this fully hardened after 6 hours at room temperature. The ABS (internal solid model part) was broken and removed, leaving the hollow 3D model.
All procedures were performed at this institute: Toshihiro Mashiko, 9) an inventor of this 3D model system, closely instructed us on its use the first time, after which we easily created the models ourselves. Creating this hollow 3D model required approximately 3 days and 10,000 Japanese yen (90 US dollars). Comparison of PDA structure between angiography versus 3D model: To determine whether the 3D model precisely reproduced the PDA structure, we compared the PDA structure revealed by angiography and that reproduced by the cine-image of the 3D model. Between the two, the widest diameter, narrowest diameter, and entire length of the duct were compared in a 54-year-old female patient ( Figure 3) . Pre-procedural simulation: We simulated the procedure, and tentatively selected the device (ADO or AVP, and its size), and actually deployed the device for this model. Then, we examined whether the device fitted the lesion (PDA) and whether the device protruded from the PDA-SIMULATION OF PATENT DUCTUS ARTERIOSUS OCCLUSION The hollow 3D model. C-E: A simulation process for deployment of the devices in the hollow 3D model. C: ADO 16/14 is too short and it does not fit the aneurysm-like ductus. D: AVP-14 mm is placed, with its three parts being deployed in PA, the duct, and DAO, respectively. AVP-14 mm was too long and its aortic part protruded into DAO (arrows). E: AVP-12 mm is placed. The central part of AVP-12 mm just fitted the aneurysm-like ducts. Protrusion of the device into DAO can no longer be noted. This AVP (12 mm) was actually used with success. AO indicates aorta; DAO, descending aorta; PA, pulmonary artery; MDCT, multi-detector computed tomography; PDA, patent ductus arteriosus; ADO, AMPLATZER TM Duct Occluder; and AVP, AMPLATZER TM Vascular Plug II.
ductal-end (either the pulmonary artery side or descending aorta side). After this series of simulations, we determined/selected the optimal device and its size, and used it for an individual patient (Figure 4) .
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Catheter procedure and selection of device (ADO or AVP, and its size): One experienced operator (KK) performed the procedures for device deployment using standard techniques.
10) The PDA morphology was classified using the Krichenko classification.
11) Before we detached the device, we performed angiography to confirm that the device had been placed in the correct position, and that its end (edge) did not protrude too much into the pulmonary artery or descending aorta. We selected the device (ADO or AVP) and its size as follows. In the control group (patients without 3D model use), we determined them during the procedure. The pre-device-deployment angiography revealed the shape of PDA. The device and its size were determined based on the diameter of the narrowest part and length of PDA. The size of the device selected was 2-3 mm larger than the narrowest portion of PDA. 7, 8) In the study group, we determined them beforehand based on our simulation. Incidence of procedural or device change: We may sometimes have to change the approach procedure/route or device, which is usually performed/judged in a "trial and error manner" in the operating suite. The incidence of procedural/device change was compared between the 2 groups. Change in procedural/fluoroscopic times and the amount of contrast medium: The procedural time was defined as the time between sheath insertion and removal. The fluoroscopic time was automatically recorded. The amount of contrast medium used and the above 2 factors were compared between the 2 groups. Definition of procedural success versus failure and complications: When the device fitted well and ductal flow after the procedure disappeared, it was defined as "success". If the ductal flow remained at the time of discharge, or if the device was dislodged, it was defined as "failure". We also measured other major complications associated with the catheter procedure, defined as "complications". Analysis of doctors' understanding based on questionnaire: We used this model at staff meetings to decide on the treatment strategy. We attempted to determine whether this 3D model improved doctors' understanding using a questionnaire. This questionnaire was completed once (December 2017) by 8 doctors (cardiologists) based on doctors' experience involving all 7 patients. The following were asked: whether the 3D model: 1) improved understanding of the PDA structure, 2) simplified the decision on how to place the closure device, 3) improved the selection of an optimal device/size, 4) was easy to "handle", and 5) was useful in practice. The answers were selected from 5 options: 1) totally disagree, 2) partly disagree, 3) partly disagree and partly agree, 4) partly agree, or 5) totally agree. Statistics: The values are expressed as median and interquartile ranges. Informed consent: The Institutional Review Board (IRB) of Jichi Medical University approved this study. Informed consent was obtained from all patients/parents for 3D-model employment. Informed consent was not needed for historical control patients who underwent PDA closure without this model since data were obtained only from the medical charts: an announcement of opt-out being possible was published on our department homepage. AVP had not been approved for PDA closure in Japan. In cases of a large/long PDA, we believed that AVP may be more effective, and so it was used. 12) For AVP use, we obtained informed consent from patients and IRB approval.
Results
Comparison of the PDA structure between angiography versus 3D model provided the following data. The measured values, i.e., widest diameter, narrowest diameter, and the entire length of the duct, between pre-procedural angiographic versus 3D-model cine-images were: 9.9 versus 9.7, 3.6 versus 3.7, and 17.2 versus 17.7 mm, respectively. Although the measured values differed slightly between the 2, this degree of difference is considered permissible for simulation. Table II indicates the backgrounds of study (n = 7) versus control (n = 4) patients. The study group, compared with the control group, included fewer Krichenko A types (requiring easier device procedures) and included B and D types (requiring more difficult procedures 4, 7) ). The PDA structures of the study group patients were wider and longer. The study group was more likely to exhibit calcification around PDA. Table III indicates the procedural outcomes. Times for fluoroscopy and the total procedure were shorter in the study group than in the control group. The total volume of contrast medium with body weight compensation did not differ, but that without compensation was larger in the study group than the control group. No patients required a device change during the procedure in the study group, meaning that the preplanned device/size based on the 3D model was actually used in each patient, whereas a half (2/4) required it in the control group. Complete closure was achieved in all patients of both groups and no complications occurred in either group. Thus, all patients were classified as "success" according to the criteria described in the Methods.
Here, we briefly describe one patient from the study group. In this patient (54-year-old female patient: study group), the ductal shape was complicated (type D: with aneurysm-like features within the duct) and the duct was long, 18.6 mm, based on CT. As described, only ADO, and not AVP, was approved for PDA closure in Japan. ADO 16/14, the maximum size, was too short. Thus, if we had been obliged to determine it solely based on the angiographic images, it may have been very difficult to determine whether AVP (not ADO) was appropriate, and if so, the size needed. We simulated the procedure with the 3D model beforehand, which indicated that ADO 16/ 14 was too short and did not fit the aneurysm-like ductus, as expected. We selected 12 mm-AVP as the optimal device (Figure 4) , enabling us to ask the IRB to approve the use of AVP for PDA closure in this specific patient. AVP 12 mm just fitted, with successful PDA closure.
Almost all 8 doctors gave "full marks = 5" in response to all 5 questions: in detail, the scores in response to question Q1 (understanding the anatomy) and Q5 (clinical usefulness) were full marks (all 5), those for Q2 (understanding the procedure) and Q3 (device selection) were an average of 4.9, and that for Q4 (easy to handle) was an average of 4.8. There were no doctors who gave scores !3.
Discussion
The present 3D model precisely reproduced PDA. This study demonstrated that the hollow 3D model may be effective for transcatheter PDA closure for the following 3 reasons. First, this model enabled pre-procedural selection of the closure device and its size. Second, in the study group, compared with the control group, the fluoroscopic and total procedural times were shorter. Third, this model improved physician understanding of the procedures.
Firstly, using the present 3D model, we could select the closure device and its size beforehand. In the study group, no patients required a device change during the procedure, whereas one half (2/4) of the patients in the control group required it. The selections of the closure device and its size fundamentally depend on the experience of the practitioners. Usually, practitioners are obliged to select them during the procedure mainly based on angiographic images of PDA. This study indicated that even experienced practitioners may make erroneous decisions if they depend solely on the images during the procedures.
In the study group, we could simulate device closure and select optimal devices/sizes. The 3D model was easy to handle and translucent, so we could check the device position from any angle. The pre-decided device and its size were in full agreement with the actually deployed ones. This 3D model yielded much more information to help decide upon the procedure and select devices/their sizes.
Secondly, patients of the study group, compared with those of the control group, showed shorter fluoroscopic and total procedural times, which are widely used to test the effectiveness of some new catheter interventions. 13) This suggests that 3D-model use may be beneficial for patients. For example, it may enable a reduction in irradiation doses and also in the amount of anesthetic agents. The total volume of contrast medium "without" body weight compensation was larger in the study group than the control group. Two adult patients in the study group had complicated-structured PDA (Krichenko D or E type), requiring a relatively large amount of contrast medium (180 and 190 cm 3 , respectively). The percentage of patients requiring !100 cm 3 of the medium was roughly the same between the study group versus control group (3/7 versus 2/4). The total volume of contrast medium "with" body weight compensation, which is now widely used in catheter-procedure studies such as the present study, did not differ between the 2 groups.
PDA structures of the study group were wider and longer and involved Krichenko B/D types, and some showed calcification. Wider and longer PDA and B/D type-PDA may necessitate longer procedural/fluoroscopic times. 4, 7) Calcification reduces duct elasticity, leading to difficulty in using the antegrade approach (passing the catheter from the pulmonary artery to the descending aorta), and, thus, a retrograde approach (wire-assisted technique) is sometimes needed, leading to longer procedural/fluoroscopic times 14) : one patient in the study group needed it. Even with this background, the study group showed shorter fluoroscopic/procedural times, which may suggest that the 3D model made the procedure easier.
Thirdly, this 3D model improved physician understanding. This is consistent with previous studies on the effectiveness of 3D models to treat many organs other than the heart. 9) Regarding the 3D model for PDA, there has been, to our knowledge, only one study in canines, in which 3D model use improved veterinary-cardiologists' understanding. 15) No previous report, to the best of our knowledge, has described how the 3D model for PDA closure affected physician understanding in clinical practice.
In this study, a single doctor (KK), certified as an operator by the Society of Japanese Pediatric Interventional Cardiology, performed the most important procedures (device deployment/detachment). This model was still effective. Generally speaking, less experienced practitioners may show a "steeper" learning curve compared with highly experienced ones, and thus, this model may be much more effective for the less-experienced practitioner.
The present study population was small. The control group consisted of 4 patients. This was because we attempted to test the effect of the 3D model only in "difficult" cases and chose a strict inclusion criterion. If the number of patients in one group is < 5 when comparing the frequencies or median values between two groups, the statistical power is very low, and so there is no merit in performing a statistical test. 16) According to this statistical rule, we only showed the values without performing any statistical tests. Now that we believe the 3D model is effective for PDA closure, increasing the number of "control patients" is ethically impossible. Here, we wish to add other data. Before September 30th, 2016 ("before" period), we performed 4 "coil embolizations" for difficult (CT-requiring) cases. We included these 4 patients in the "control group", and then compared the two groups (7 [study group] versus 8 [control group]). Although the patients in the study group had significantly poorer heart conditions (advanced NYHA stage and a higher cardiothoracic ratio) with a significantly longer PDA, the total procedural/fluoroscopic times and total volume of contrast medium with body weight compensation did not differ between the 2 groups (data not shown, available on request).
In conclusion, we demonstrated that our hollow 3D model enabled pre-procedural selection of the device/size and shortened the fluoroscopic and total procedural times in transcatheter PDA closure. This model improved physician understanding of the procedure. It can be easily created in a reproducible manner by medical-engineering non-specialists within a single institute. It costs only 90 US dollars. A study should be conducted to determine who benefits the most and who may not require this 3D model.
